| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
CLINICAL SCIENCE |


*Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, and
ANZDATA Registry, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
Correspondence to: Dr. K. R. Polkinghorne, Department of Nephrology, Monash Medical Centre, 246 Clayton Rd., Clayton, Melbourne, Victoria 3168, Australia. Phone: 61-3-95943529; Fax: 61-3-95946530; E-mail: kevan.polkinghorne{at}med.monash.edu.au
ABSTRACT. The native arteriovenous fistula (AVF) is the preferred vascular access because of its longevity and its lower rates of infection and intervention. Recent studies suggest that the AVF may offer a survival advantage. Because these data were derived from observational studies, they are prone to potential bias. The use of propensity scores offers an additional method to reduce bias resulting from nonrandomized treatment assignment. Adult (age 18 yr or more) patients who commenced hemodialysis in Australia and New Zealand on April 1, 1999, until March 31, 2002, were studied by using the Australian and New Zealand Dialysis and Transplant Association (ANZDATA) Registry. Cox regression was used to determine the effect of access type on total mortality. Propensity scores were calculated and used both as a controlling variable in the multivariable model and to construct matched cohorts. The catheter analysis was stratified by dialysis duration at entry to ANZDATA to satisfy the proportional-hazard assumption. There were 612 deaths in 3749 patients (median follow-up, 1.07 yr). After adjustment for confounding factors and propensity scores, catheter use was predictive of mortality. Patients with arteriovenous grafts (AVG) also had a significantly increased risk of death. Effect estimates were also consistent in the smaller propensity scorematched cohorts. Both AVG and catheter use in incident hemodialysis patients are associated with significant excess of total mortality. Reducing catheter use and increasing the proportion of patients commencing hemodialysis with a mature AVF remain important clinical objectives.
This article has been cited by other articles:
![]() |
S. P. McDonald, M. R. Marshall, D. W. Johnson, and K. R. Polkinghorne Relationship between Dialysis Modality and Mortality J. Am. Soc. Nephrol., January 1, 2009; 20(1): 155 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Graham, S. Hiremath, P. O. Magner, G. A. Knoll, and K. D. Burns Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3585 - 3591. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Moist, L. Trpeski, Y. Na, and C. E. Lok Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Registry 2001-2004 Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1726 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lobbedez, A. Lecouf, M. Ficheux, P. Henri, B. H. de Ligny, and J.-P. Ryckelynck Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3290 - 3294. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ethier, D. C. Mendelssohn, S. J. Elder, T. Hasegawa, T. Akizawa, T. Akiba, B. J. Canaud, and R. L. Pisoni Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3219 - 3226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Craig and J. M. Hunter Recent developments in the perioperative management of adult patients with chronic kidney disease Br. J. Anaesth., September 1, 2008; 101(3): 296 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli Randomized Trials in Hemodialysis Patients: Time to Step Up to the Plate JAMA, May 14, 2008; 299(18): 2205 - 2207. [Full Text] [PDF] |
||||
![]() |
M. T. James, J. Conley, M. Tonelli, B. J. Manns, J. MacRae, B. R. Hemmelgarn, and for the Alberta Kidney Disease Network Meta-analysis: Antibiotics for Prophylaxis against Hemodialysis Catheter-Related Infections Ann Intern Med, April 15, 2008; 148(8): 596 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Al-Ghonaim, B. J. Manns, D. J. Hirsch, Z. Gao, M. Tonelli, and for the Alberta Kidney Disease Network Relation between Access Blood Flow and Mortality in Chronic Hemodialysis Patients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 387 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Lok Fistula First Initiative: Advantages and Pitfalls Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1043 - 1053. [Full Text] [PDF] |
||||
![]() |
H. Wasse, N. Kutner, R. Zhang, and Y. Huang Association of Initial Hemodialysis Vascular Access with Patient-Reported Health Status and Quality of Life Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 708 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schon, S. W. Blume, K. Niebauer, C. S. Hollenbeak, and G. de Lissovoy Increasing the Use of Arteriovenous Fistula in Hemodialysis: Economic Benefits and Economic Barriers Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. I. Clark, R. A. Cohen, A. Kwak, J. F. Markmann, S. W. Stavropoulos, A. A. Patel, M. C. Soulen, J. I. Mondschein, S. Kobrin, R. D. Shlansky-Goldberg, et al. Salvage of Nonmaturing Native Fistulas by Using Angioplasty Radiology, December 1, 2006; 242(1): 286 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brenner, A. K. Singh, D. Campbell, F. Frei, and W. C. Winkelmayer Associations between Demographic Factors and Provider Structures on Cost and Length of Stay for Hemodialysis Patients with Vascular Access Failure Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 455 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Owen, R. J. Walker, L. Edgell, J. Collie, L. Douglas, T. D. Hewitson, and G. J. Becker Implementation of a pre-dialysis clinical pathway for patients with chronic kidney disease Int. J. Qual. Health Care, April 1, 2006; 18(2): 145 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Mendelssohn, J. Ethier, S. J. Elder, R. Saran, F. K. Port, and R. L. Pisoni Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II) Nephrol. Dial. Transplant., March 1, 2006; 21(3): 721 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 4: Vascular Access J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S16 - S23. [Full Text] [PDF] |
||||
![]() |
B. C. Astor, J. A. Eustace, N. R. Powe, M. J. Klag, N. E. Fink, J. Coresh, and for the CHOICE Study Type of Vascular Access and Survival among Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1449 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Johnson, C. van Eps, D. W. Mudge, K. J. Wiggins, K. Armstrong, C. M. Hawley, S. B. Campbell, N. M. Isbel, G. R. Nimmo, and H. Gibbs Randomized, Controlled Trial of Topical Exit-Site Application of Honey (Medihoney) versus Mupirocin for the Prevention of Catheter-Associated Infections in Hemodialysis Patients J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1456 - 1462. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673